rfhg_101009.1

Basic information about the TSS

---

TSS ID: rfhg_101009.1 Species: human Chr: chr7		Start: 140696957 End: 140697004 Strand: +
Source datasets	PRJNA615891
Protocol	SLIC_CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4039705,EH38E2596577)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000460088.5:0 ENST00000472695.5:0 GeneID: 4708 HGNC/MGI_ID: HGNC:7697 UniProt_ID: C9IZZ2 Nearer transcript ids and distances: ENST00000476470.5:153 ENST00000464566.5:-209 CR542121:-212 ENST00000471136.5:220 BC001168:-241 ENST00000476181.5:-247 BC063026:-247 ENST00000464564.6:-248 ENST00000247866.9:-249 NM_004546.3:-249 ENST00000465506.5:-267 ENST00000461457.1:-269 AF050639:-269 AF067166:-276 ENST00000476279.5:-286 view more...

Gene_name: NADH:ubiquinone oxidoreductase subunit B2 Gene_symbol: NDUFB2 Gene_synonyms: AGGG CI-AGGG Gene_source: HGNC:7697

TATA-Box annotation

---

Distance to TSS:	97
Nearest PromoterID:	NR_024454
Entrez ID:	100134713
Nearest Unigene:	Hs.534141
Nearest Refseq:	NR_024454
Nearest Ensembl:	ENSG00000240889
Gene Name:	NADH:ubiquinone oxidoreductase subunit B2
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.106383
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NDUFB2 p2@NDUFB2 p3@NDUFB2
Sample		p1@NDUFB2	p2@NDUFB2	p3@NDUFB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	30.97	1.56	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.37	0.81	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	34.72	1.35	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	33.47	0.83	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	32.85	2.02	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.85	1.16	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	36.17	1.31	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	36.09	0.97	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	45.74	0.85	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	3.48	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	16.57	2.02	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	0.81	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	33.53	2.42	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.71	2.41	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	29.64	2.42	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.12	1.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.28	1.09	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.20	2.95	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	2.67	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	46.34	2.26	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	34.62	2.41	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	37.80	2.24	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	27.40	1.03	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	35.19	2.43	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.28	2.84	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	35.77	3.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.03	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	40.55	2.12	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.03	2.26	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	35.11	1.09	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.54	1.88	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.95	1.37	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	33.34	1.90	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	25.24	0.82	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	33.66	1.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	37.17	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	49.05	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.84	0.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	41.06	1.89	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	42.49	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	36.23	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	37.77	1.76	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.49	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.61	1.40	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	46.38	1.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	46.30	1.40	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	34.07	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	48.28	2.68	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	42.37	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	48.12	1.62	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.10	1.23	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.69	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.71	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.45	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	40.27	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	31.23	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	30.47	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.29	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	46.84	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	27.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	18.51	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	39.01	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	34.32	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	29.57	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	36.92	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	27.30	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	30.25	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	31.90	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.76	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.86	0.93	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.63	1.22	0.00
Adipocyte - breast, donor1	11376-118A8	47.52	1.11	1.11
Adipocyte - breast, donor2	11327-117E4	57.11	1.28	0.64
Adipocyte - omental, donor1	11473-119C6	30.28	1.02	0.64
Adipocyte - omental, donor2	11474-119C7	97.17	3.74	2.24
Adipocyte - omental, donor3	11475-119C8	100.48	2.34	1.34
Adipocyte - perirenal, donor1	11476-119C9	90.59	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	47.28	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	33.42	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	56.48	1.04	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	50.85	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	33.46	1.29	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	40.14	1.67	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	35.86	1.76	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	98.61	0.88	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	46.80	1.61	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	24.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	42.85	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	116.87	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	58.02	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	52.03	0.98	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	54.20	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	55.69	0.88	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	135.54	1.79	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	29.95	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	71.96	0.36	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	71.96	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	84.03	0.62	1.03
Anulus Pulposus Cell, donor1	11248-116E6	35.47	2.17	0.34
Anulus Pulposus Cell, donor2	11463-119B5	72.49	1.47	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	62.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	59.91	0.43	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	51.37	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	66.36	1.20	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	74.61	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	50.17	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	52.31	0.65	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	72.33	1.46	2.91
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	42.17	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	76.83	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	53.70	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	57.67	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.03	1.48	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	60.05	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	88.82	0.90	2.26
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	56.26	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	83.32	1.70	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	41.96	1.07	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	57.55	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	74.31	0.83	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	68.44	1.37	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	69.42	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	92.97	0.76	1.90
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	32.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	74.67	2.85	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	75.03	1.28	1.50
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	58.33	0.77	2.84
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	54.43	0.47	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	68.49	2.25	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	49.23	2.14	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	57.33	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	67.14	1.20	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	61.78	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	75.27	2.54	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	78.95	1.53	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	61.63	3.18	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	76.38	1.73	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	82.13	0.85	2.12
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	52.49	0.58	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	60.46	0.00	5.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	79.17	1.19	1.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	73.76	1.93	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	28.88	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	68.52	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	84.60	0.69	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	92.79	2.29	2.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	70.40	1.45	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	53.24	0.31	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	70.27	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	68.74	1.33	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	51.88	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	67.57	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	57.99	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	47.98	0.36	1.09
Astrocyte - cerebellum, donor1	11500-119F6	90.02	1.97	0.49
Astrocyte - cerebellum, donor2	11580-120F5	130.42	3.25	0.51
Astrocyte - cerebellum, donor3	11661-122F5	48.24	1.05	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	64.84	3.49	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	65.36	2.10	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	81.29	2.54	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	50.12	3.33	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	50.99	2.51	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	45.40	2.16	0.23
Basophils, donor1	12241-129G9	32.43	1.31	0.52
Basophils, donor2	12242-129H1	42.21	1.44	0.36
Basophils, donor3	12243-129H2	33.52	0.44	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	41.61	0.86	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	113.38	2.29	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	70.30	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	45.54	1.25	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	20.50	0.46	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	45.35	2.52	1.26
Burkitt's lymphoma cell line:DAUDI	10422-106C8	77.70	3.30	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	62.65	6.99	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	103.29	4.16	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	33.25	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	15.78	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	27.00	1.32	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.82	1.70	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	48.90	1.52	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	47.67	1.31	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	16.62	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	13.88	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	20.37	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.89	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.35	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.19	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	36.56	0.22	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	12.41	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	15.84	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	15.17	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	20.55	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	36.02	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	19.68	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.48	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	17.46	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.72	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.10	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	22.30	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	19.47	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.61	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	21.94	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	14.47	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	16.73	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	33.63	0.86	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.33	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.68	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	20.18	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	60.81	1.09	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	45.74	0.46	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	72.13	1.73	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	45.47	0.93	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	39.82	1.05	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	29.21	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	114.57	0.26	2.04
CD14-CD16+ Monocytes, donor2	11800-124C9	51.82	0.66	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	67.59	1.05	2.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	113.81	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	101.70	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	98.38	3.11	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	84.75	2.13	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	88.45	1.61	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	83.53	0.70	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	99.61	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	118.65	1.32	2.64
CD19+ B Cells, donor1	11544-120B5	12.33	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	17.41	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	11.61	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	39.19	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	39.95	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	37.15	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	35.96	2.81	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	98.07	1.88	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	108.46	2.71	0.68
CD4+ T Cells, donor1	11225-116C1	19.64	3.57	0.36
CD4+ T Cells, donor2	11306-117C1	42.87	3.67	1.22
CD4+ T Cells, donor3	11382-118B5	29.28	3.05	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	52.83	1.53	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	46.27	2.70	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	32.77	4.02	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	65.42	3.32	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	84.98	9.13	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	3.30	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	35.84	1.73	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	62.19	2.88	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	44.49	3.22	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	51.55	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	47.17	6.29	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	29.92	3.52	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	38.37	1.26	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	56.93	1.87	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	55.47	3.68	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	42.69	2.99	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	36.44	4.29	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	57.11	1.67	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	54.59	1.52	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	50.44	1.68	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	91.51	6.07	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	73.22	5.63	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	45.76	3.49	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	110.85	4.95	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	123.71	2.77	7.39
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	173.08	2.79	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	110.22	6.92	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	102.08	4.66	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	80.08	6.16	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	97.05	3.94	3.22
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	170.35	8.31	2.77
CD8+ T Cells, donor1	11226-116C2	28.81	2.62	0.33
CD8+ T Cells, donor2	11307-117C2	30.03	2.63	1.13
CD8+ T Cells, donor3	11383-118B6	36.36	2.27	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.25	1.15	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	18.45	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.14	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.52	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	15.12	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	17.74	1.59	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.77	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.69	1.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	24.62	1.17	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.96	1.51	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.02	0.87	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	34.90	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.51	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.50	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	15.66	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	21.25	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	20.43	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.80	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	31.69	1.58	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	30.45	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	22.12	0.64	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.92	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.01	0.39	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	10.44	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	10.49	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	38.38	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	56.33	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	75.98	1.26	0.95
Chondrocyte - de diff, donor1	11261-116G1	83.55	1.73	1.39
Chondrocyte - de diff, donor2	11338-117F6	46.20	1.78	0.36
Chondrocyte - de diff, donor3	11410-118E6	44.72	1.02	0.68
Chondrocyte - re diff, donor2	11339-117F7	49.24	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	49.34	2.43	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	49.23	2.64	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	58.57	1.50	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	51.77	1.68	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	51.44	1.28	1.01
Corneal Epithelial Cells, donor1	11526-119I5	62.14	2.85	0.44
Corneal Epithelial Cells, donor2	11606-120I4	47.78	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	81.29	1.28	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	41.11	1.16	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	68.44	0.63	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	93.17	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	76.67	0.32	2.38
Dendritic Cells - plasmacytoid, donor1	11228-116C4	37.58	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	65.29	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	78.40	1.45	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	38.86	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	49.29	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	43.55	0.85	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	33.42	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	51.48	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	40.23	0.71	0.71
Endothelial Cells - Artery, donor3	11413-118E9	42.95	1.23	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	48.76	0.89	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.21	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.06	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	70.42	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	58.84	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	45.66	0.99	0.71
Endothelial Cells - Thoracic, donor1	11266-116G6	69.22	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	61.85	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	49.82	1.37	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	49.10	2.82	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	58.25	1.34	0.00
Endothelial Cells - Vein, donor1	11267-116G7	39.81	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.75	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	51.18	1.26	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	51.55	1.71	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.59	2.05	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	52.34	0.88	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	60.13	1.30	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	52.88	1.46	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	27.98	0.96	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	47.14	0.95	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	14.23	1.32	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.84	1.99	0.33
Fibroblast - Cardiac, donor1	11268-116G8	53.53	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	36.38	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	57.25	1.26	0.79
Fibroblast - Cardiac, donor4	11452-119A3	48.50	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	63.33	1.78	0.38
Fibroblast - Cardiac, donor6	11460-119B2	86.86	1.06	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	47.30	1.61	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.97	1.29	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	49.80	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	52.36	1.85	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	24.59	2.04	0.51
Fibroblast - Dermal, donor1	11269-116G9	59.16	2.58	1.88
Fibroblast - Dermal, donor2	11346-117G5	41.51	3.77	0.47
Fibroblast - Dermal, donor3	11418-118F5	55.37	2.90	0.97
Fibroblast - Dermal, donor4	11450-119A1	67.94	3.84	0.23
Fibroblast - Dermal, donor5	11454-119A5	62.80	1.74	0.52
Fibroblast - Dermal, donor6	11458-119A9	79.59	2.60	0.81
Fibroblast - Gingival, donor1	11237-116D4	49.35	2.08	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	33.27	2.36	0.26
Fibroblast - Gingival, donor2	11318-117D4	64.57	2.90	0.66
Fibroblast - Gingival, donor3	11394-118C8	27.85	1.74	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	34.28	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	31.89	1.06	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	41.78	0.94	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	35.43	0.95	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	11.29	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	41.97	0.58	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.95	0.95	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	34.55	1.43	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	29.64	2.49	0.59
Fibroblast - Lung, donor1	11270-116H1	31.27	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	47.91	2.32	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	57.48	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	72.73	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	48.42	2.52	0.28
Fibroblast - Mammary, donor1	11540-120B1	38.16	0.81	0.41
Fibroblast - Mammary, donor2	11620-122A9	79.88	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	59.16	2.33	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	45.96	2.58	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.27	2.14	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	44.65	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	71.01	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.55	2.09	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	75.27	0.88	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	40.84	1.22	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	56.80	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	68.40	1.58	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.68	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	30.02	2.31	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	35.87	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	17.75	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	61.75	1.40	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.26	0.76	0.76
Fibroblast - skin normal, donor1	11553-120C5	49.39	1.64	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	18.85	0.60	1.20
Fibroblast - skin normal, donor2	11561-120D4	68.31	1.31	1.41
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	23.27	1.21	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.99	0.99	1.16
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	45.99	1.03	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.41	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	78.29	1.49	1.28
Fibroblast - skin walker warburg, donor1	11554-120C6	57.69	0.84	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	69.16	1.25	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	39.22	0.00	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	54.09	0.87	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.71	0.00	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.48	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	48.23	5.36	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	44.67	3.83	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	139.78	8.27	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	116.92	5.52	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	61.42	3.42	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	111.35	6.14	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	129.26	3.97	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	84.47	4.89	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	108.79	6.63	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	57.38	4.66	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	47.41	1.85	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	45.40	1.88	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	32.46	2.73	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.58	3.74	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	30.50	1.83	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	36.28	2.97	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	32.89	3.11	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	27.32	4.81	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.12	2.66	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	38.31	1.75	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.57	1.79	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	42.14	2.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.79	1.70	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	31.39	1.77	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.87	2.39	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.10	2.56	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	38.06	2.55	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.69	2.41	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.53	2.65	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	41.88	3.71	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.36	4.50	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	41.36	2.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.77	3.53	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	42.43	3.69	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.88	2.11	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.98	5.13	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.47	2.27	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	44.92	3.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.89	2.74	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	39.31	2.72	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	35.35	2.85	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	27.21	2.52	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.46	1.67	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.52	2.67	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	45.44	1.22	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	56.22	1.81	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	49.34	2.98	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	45.35	2.77	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.26	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.37	1.71	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.47	2.82	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	10.67	2.80	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	79.42	4.38	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	50.85	5.55	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	64.85	6.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	172.74	5.01	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	159.36	4.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	75.64	4.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	138.59	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	106.37	3.09	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	109.10	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	121.72	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	109.36	2.28	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	78.65	2.06	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	89.49	3.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	72.56	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	47.81	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	80.15	4.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	80.50	4.42	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	141.99	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	72.16	5.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	70.74	4.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	140.61	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	93.61	2.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	86.30	1.61	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	173.86	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	82.65	3.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	80.84	3.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	139.12	4.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	45.08	7.32	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	59.91	3.77	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	65.59	6.61	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	61.56	6.64	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	71.72	7.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.59	3.59	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	74.50	8.39	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	73.19	11.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	74.68	8.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.91	7.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	52.56	7.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	105.06	3.58	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	109.67	3.40	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	53.64	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	46.57	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	34.86	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	30.13	1.90	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	54.72	3.76	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	71.25	2.55	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	57.39	3.04	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	59.61	2.73	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	70.50	3.50	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	51.15	3.87	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	55.11	2.80	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	75.47	3.61	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	62.44	3.95	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	63.75	2.88	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	84.50	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	57.99	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	50.23	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	84.65	1.06	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	79.92	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	67.31	1.05	1.22
Hepatocyte, donor1	11523-119I2	69.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	38.78	0.00	0.00
Hepatocyte, donor3	11684-122I1	57.67	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	73.75	3.26	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	41.95	2.10	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	56.67	0.41	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	66.86	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	59.53	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	51.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	46.68	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	46.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	64.30	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	42.83	3.15	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	74.24	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	43.28	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	64.40	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	46.45	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	38.62	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	43.40	4.02	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	66.48	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	61.36	3.78	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	56.23	4.53	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	46.27	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	50.82	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	29.97	2.55	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	51.03	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	1.43	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	49.69	4.32	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	63.22	7.02	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	36.16	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	21.80	4.36	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	38.79	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	39.58	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	22.20	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.79	0.41	0.65
Keratinocyte - epidermal, donor2	11349-117G8	21.67	0.59	1.76
Keratinocyte - epidermal, donor3	11421-118F8	47.52	1.33	0.38
Keratinocyte - oral, donor1	11251-116E9	41.66	1.59	0.68
Keratocytes, donor1	11527-119I6	41.60	5.85	0.34
Keratocytes, donor2	11607-120I5	65.62	3.52	0.00
Keratocytes, donor3	11688-122I5	22.92	2.57	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	76.93	6.59	4.40
Lens Epithelial Cells, donor1	11529-119I8	46.39	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	45.33	1.85	0.58
Lens Epithelial Cells, donor3	11690-122I7	47.83	0.91	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	64.39	0.24	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	51.91	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	52.89	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	45.17	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	50.11	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	61.13	0.11	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	47.61	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	51.07	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	45.88	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	34.41	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	55.06	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	69.06	1.30	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	56.10	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	44.13	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	48.48	0.82	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	45.58	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	48.01	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	49.96	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	47.72	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	41.29	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	48.29	0.75	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	52.86	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	49.55	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	53.44	0.45	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	41.99	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	49.21	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	56.69	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	44.71	0.00	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	47.98	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	55.56	0.53	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	47.00	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	44.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	52.65	0.37	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	47.39	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	56.58	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	53.35	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	42.78	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	40.17	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	48.29	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	45.51	0.71	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	47.02	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	57.57	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	64.10	1.43	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	40.51	0.65	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	63.80	0.24	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	54.20	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	45.85	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	59.97	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	67.98	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	61.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	47.50	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	39.77	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	56.27	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	60.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	27.82	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	49.96	2.38	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	51.12	1.36	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	48.28	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	54.47	1.35	2.70
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	34.68	0.54	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	45.70	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	61.75	0.71	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.31	0.67	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	46.86	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	54.43	0.53	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	60.46	1.32	1.32
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	42.95	0.61	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	60.34	0.00	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	66.64	1.67	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	46.80	0.84	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	47.40	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	63.29	1.16	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	42.15	1.20	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	75.24	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	34.29	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	39.83	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	39.14	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	50.66	0.77	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	35.10	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	50.87	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	47.00	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	40.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	56.02	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	44.96	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	45.66	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	46.24	2.57	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	54.97	0.67	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.20	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.01	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	44.34	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	30.06	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	51.18	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	50.01	1.48	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	69.78	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	60.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	46.42	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.07	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	65.15	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	47.85	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	28.23	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	56.82	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	40.56	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	53.00	2.23	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	39.49	1.17	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	64.87	0.52	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	39.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	58.30	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	59.40	0.39	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	35.95	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	59.12	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.15	0.40	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	34.03	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	40.81	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	48.64	1.14	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	32.53	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	38.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	47.54	1.27	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	28.25	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	40.23	1.72	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	40.11	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.89	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	39.94	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	28.97	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	39.67	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	48.32	1.39	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.77	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	42.24	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	40.01	0.40	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	24.78	1.84	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	36.45	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	43.88	0.57	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	26.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.83	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	36.97	0.45	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	34.31	0.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	51.06	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	0.00	6.24
Macrophage - monocyte derived, donor1	11232-116C8	82.73	0.68	2.05
Macrophage - monocyte derived, donor2	11313-117C8	77.07	0.37	1.10
Macrophage - monocyte derived, donor3	11389-118C3	85.46	0.26	1.44
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	147.09	0.53	2.66
Mallassez-derived cells, donor2	11929-125I3	55.14	0.48	0.95
Mallassez-derived cells, donor3	11930-125I4	75.75	0.69	0.42
Mammary Epithelial Cell, donor1	11273-116H4	39.26	1.30	0.80
Mammary Epithelial Cell, donor2	11350-117G9	41.41	0.29	0.29
Mammary Epithelial Cell, donor3	11422-118F9	32.67	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	29.83	1.36	0.00
Mast cell, donor1	11563-120D6	48.23	1.73	0.97
Mast cell, donor2	11565-120D8	33.58	0.89	0.30
Mast cell, donor3	11566-120D9	42.10	2.25	1.35
Mast cell, donor4	11567-120E1	27.30	2.66	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	54.34	2.22	1.33
Mast cell, expanded and stimulated, donor8	11942-126A7	26.85	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	61.15	1.72	2.41
Mast cell, expanded, donor8	11941-126A6	28.29	1.51	0.17
Melanocyte - dark, donor1	11502-119F8	83.38	1.19	0.10
Melanocyte - dark, donor2	11582-120F7	57.45	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	67.51	1.52	0.80
Melanocyte - light, donor1	11274-116H5	21.16	0.94	0.24
Melanocyte - light, donor2	11351-117H1	20.47	0.68	0.00
Melanocyte - light, donor3	11423-118G1	40.76	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	59.56	3.02	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	45.72	1.88	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	46.07	2.68	0.27
Meningeal Cells, donor1	11493-119E8	60.79	1.61	0.37
Meningeal Cells, donor2	11573-120E7	84.51	0.88	0.00
Meningeal Cells, donor3	11654-122E7	38.22	1.87	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	87.83	2.85	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	23.65	1.41	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	44.68	1.31	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	71.95	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	58.13	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	40.87	0.42	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	46.75	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	70.32	1.54	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	70.87	3.65	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	71.61	1.43	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	50.83	2.77	1.52
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	73.23	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	27.63	0.92	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	53.12	0.89	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	81.33	0.64	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	80.81	1.06	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	41.59	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	89.99	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	79.02	1.33	2.12
Mesothelial Cells, donor2	12156-128G5	107.10	2.50	0.50
Mesothelial Cells, donor3	11402-118D7	53.04	1.08	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	35.11	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	87.43	0.74	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	64.78	0.59	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	95.77	0.00	2.48
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	52.69	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	85.59	0.75	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	42.36	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	77.02	0.61	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	56.23	0.00	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	69.91	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	79.79	0.00	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	79.80	0.00	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	19.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	50.67	0.30	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	31.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	67.74	0.75	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	52.52	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.77	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	63.55	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	51.95	0.21	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	50.14	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	67.58	0.21	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	45.57	0.22	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	44.02	0.00	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.33	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	53.00	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	45.29	0.88	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	71.60	0.00	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	44.03	0.00	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	57.07	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	58.68	0.00	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	24.28	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	21.77	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	51.32	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	42.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	46.15	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	40.26	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.57	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	46.55	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	14.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	37.10	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	58.43	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	33.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	47.81	1.14	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	24.73	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	34.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	44.61	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.69	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.89	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	50.89	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	21.47	0.14	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.68	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	57.94	0.00	1.77
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.44	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	37.79	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	67.10	0.00	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	29.11	1.18	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	55.07	0.00	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	25.55	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	30.37	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	120.54	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	133.67	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	93.31	0.00	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	111.51	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	88.76	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	65.19	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	87.50	0.75	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	75.91	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	84.37	1.02	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	61.88	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	88.67	0.37	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	87.11	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	143.76	1.07	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	77.28	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	96.95	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	88.97	0.42	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	211.10	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	261.31	1.27	4.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	286.68	4.05	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	157.09	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	150.07	6.52	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	62.91	0.86	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	37.11	1.05	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	34.64	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	57.80	1.90	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	49.47	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.96	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	0.00	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	21.35	1.67	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	51.37	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.83	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	23.97	1.47	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	39.25	1.62	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.92	0.68	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.17	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	31.53	1.28	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	17.50	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	34.46	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.58	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.34	0.71	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	28.83	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	26.66	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	23.78	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	48.28	1.03	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.73	0.67	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	30.48	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	22.31	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	38.20	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	22.33	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.44	0.45	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.86	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	51.84	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.18	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.51	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	28.49	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	23.93	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.33	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.08	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.85	3.02	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	28.29	0.00	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.26	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	32.31	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	26.12	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.95	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	20.41	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	0.00	0.00
Myoblast, donor1	11241-116D8	72.43	1.12	1.49
Myoblast, donor2	11322-117D8	55.04	1.53	1.15
Myoblast, donor3	11398-118D3	70.29	0.84	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.88	4.67	1.31
Natural Killer Cells, donor1	11230-116C6	29.21	3.38	0.31
Natural Killer Cells, donor2	11311-117C6	32.87	2.41	0.90
Natural Killer Cells, donor3	11387-118C1	43.44	2.39	1.10
Neural stem cells, donor1	11275-116H6	23.23	2.54	0.00
Neural stem cells, donor2	11352-117H2	23.11	1.93	0.00
Neurons, donor1	11494-119E9	81.93	4.55	0.00
Neurons, donor2	11574-120E8	65.83	3.52	0.00
Neurons, donor3	11655-122E8	87.15	4.11	0.82
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	4.28	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	26.72	0.95	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	36.14	1.30	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	68.79	4.21	1.40
Olfactory epithelial cells, donor1	11933-125I7	36.89	0.69	0.14
Olfactory epithelial cells, donor2	11934-125I8	50.81	0.72	0.29
Olfactory epithelial cells, donor3	11935-125I9	44.72	1.02	0.68
Olfactory epithelial cells, donor4	11936-126A1	26.10	1.56	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	41.53	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	23.82	0.64	0.85
Osteoblast - differentiated, donor2	11353-117H3	72.02	2.29	3.43
Osteoblast - differentiated, donor3	11425-118G3	32.90	0.62	0.00
Osteoblast, donor1	11277-116H8	45.34	1.95	0.59
Osteoblast, donor2	11354-117H4	34.41	0.00	0.00
Osteoblast, donor3	11426-118G4	52.07	1.24	0.36
Pancreatic stromal cells, donor1	11249-116E7	36.81	1.52	1.01
Pericytes, donor1	11491-119E6	80.11	1.67	0.00
Pericytes, donor2	11571-120E5	96.21	2.04	0.68
Pericytes, donor3	11652-122E5	61.65	2.24	1.22
Perineurial Cells, donor1	11499-119F5	62.50	2.15	0.45
Perineurial Cells, donor2	11579-120F4	53.83	1.10	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	25.50	1.59	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.20	0.24	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.07	1.42	0.26
Placental Epithelial Cells, donor1	11278-116H9	82.03	1.43	0.00
Placental Epithelial Cells, donor2	11355-117H5	48.79	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	62.04	0.98	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	36.71	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	25.32	0.94	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.97	0.91	0.26
Preadipocyte - breast, donor2	11328-117E5	54.94	1.80	0.45
Preadipocyte - omental, donor1	11468-119C1	28.02	0.43	0.43
Preadipocyte - omental, donor2	11329-117E6	37.97	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	51.57	0.72	1.15
Preadipocyte - perirenal, donor1	11469-119C2	125.99	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	20.27	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	56.84	1.77	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	84.46	1.19	0.51
Preadipocyte - visceral, donor1	11280-116I2	44.34	1.86	1.12
Preadipocyte - visceral, donor2	11357-117H7	28.53	0.92	0.92
Preadipocyte - visceral, donor3	11429-118G7	45.14	1.57	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	26.70	1.21	0.30
Prostate Epithelial Cells, donor2	11331-117E8	36.70	1.35	0.68
Prostate Epithelial Cells, donor3	11404-118D9	23.15	0.61	0.18
Prostate Stromal Cells, donor1	11254-116F3	40.09	1.25	0.68
Prostate Stromal Cells, donor2	11332-117E9	45.54	0.72	1.61
Prostate Stromal Cells, donor3	11405-118E1	37.23	1.25	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	55.84	2.55	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	29.80	1.18	0.21
Renal Epithelial Cells, donor1	11517-119H5	72.53	0.51	1.52
Renal Epithelial Cells, donor2	11597-120H4	78.96	0.71	0.71
Renal Epithelial Cells, donor3	11678-122H4	23.82	1.06	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	109.62	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	85.31	0.94	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	55.06	0.89	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	53.24	3.33	1.33
Renal Mesangial Cells, donor1	11518-119H6	69.99	0.88	0.44
Renal Mesangial Cells, donor2	11598-120H5	62.70	2.51	1.88
Renal Mesangial Cells, donor3	11679-122H5	79.62	1.11	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	63.88	2.68	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	57.77	1.69	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	72.51	0.96	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	59.63	2.59	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	49.74	0.85	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	56.60	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	16.56	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	48.78	0.80	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	44.67	6.25	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.96	2.20	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.98	3.48	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	84.78	1.95	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	74.48	1.89	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	76.18	2.01	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	111.39	2.73	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	86.71	2.10	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	71.19	3.24	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	83.10	3.70	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	64.14	1.51	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	103.93	3.94	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	91.09	2.15	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	72.97	2.58	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	96.92	2.43	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	65.57	2.87	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	75.93	2.24	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	43.59	1.32	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	90.37	2.79	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	70.96	1.27	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	67.22	2.48	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	87.36	2.24	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.14	1.96	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	68.02	2.56	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	80.04	2.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	73.58	1.84	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	89.59	2.69	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	73.36	1.89	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	72.02	2.38	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	84.65	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	103.47	3.53	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	64.81	1.99	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	76.45	2.72	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	92.59	2.15	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	66.41	1.70	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	69.41	1.74	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	68.60	2.58	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	75.44	2.06	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	65.34	2.96	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	66.98	2.22	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	76.05	2.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	48.78	1.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	66.92	1.80	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	80.72	2.86	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.32	2.62	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	68.46	1.41	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	42.62	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	42.91	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	72.45	2.45	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	42.79	2.33	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	71.19	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	84.39	2.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	45.92	2.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	33.55	3.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	60.22	2.01	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	47.60	2.35	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	39.06	1.20	0.60
Schwann Cells, donor1	11498-119F4	145.38	2.44	0.56
Schwann Cells, donor2	11578-120F3	27.22	0.00	3.40
Schwann Cells, donor3	11659-122F3	65.94	0.66	1.10
Sebocyte, donor1	11220-116B5	39.99	2.19	0.00
Sebocyte, donor2	11301-117B5	31.71	1.38	1.38
Sebocyte, donor3	11378-118B1	51.73	1.03	0.82
Sertoli Cells, donor1	11255-116F4	69.58	0.00	1.66
Sertoli Cells, donor2	11333-117F1	22.59	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	26.66	2.38	0.53
Skeletal Muscle Cells, donor2	11358-117H8	18.79	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	60.19	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	102.90	3.14	0.79
Skeletal Muscle Cells, donor5	11455-119A6	90.38	1.78	0.45
Skeletal Muscle Cells, donor6	11459-119B1	98.50	2.15	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	55.44	2.27	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	65.35	2.71	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	80.16	2.98	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	33.79	1.94	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	50.66	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	77.88	1.65	0.14
Skin - palm, donor1	10286-104F7	26.86	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	36.76	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.86	0.52	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	33.78	1.53	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	32.63	0.98	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	22.62	1.48	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	23.76	0.90	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	69.12	2.78	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	16.67	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	49.38	1.76	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	30.94	0.66	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	51.59	1.18	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	56.40	2.32	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	21.02	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	33.67	3.19	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	72.92	1.11	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	90.39	1.41	1.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	66.42	3.26	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	80.03	0.89	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	59.37	0.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	64.26	3.25	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.01	1.52	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	31.07	1.52	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	57.70	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	46.60	1.62	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	47.57	3.23	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	59.30	1.57	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	52.59	1.55	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	97.01	4.31	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	84.58	2.09	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	70.33	1.71	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	22.30	1.41	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	29.09	1.21	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	65.31	1.14	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	62.19	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	58.28	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	55.66	1.73	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	51.47	1.50	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.05	1.01	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	41.76	1.66	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	43.51	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	34.89	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	34.42	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	79.77	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	56.41	1.25	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	53.98	2.95	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	54.65	1.50	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.96	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	42.60	1.58	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	63.48	0.51	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	75.21	1.50	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	54.22	1.68	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	71.81	2.01	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.29	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	51.38	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	72.47	1.55	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	73.14	1.17	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.49	1.55	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	32.53	1.32	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.38	1.12	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	34.50	1.44	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	40.60	2.56	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	36.63	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	26.66	2.79	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	23.56	3.59	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	31.77	2.51	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	41.71	3.21	0.46
Synoviocyte, donor1	11291-117A4	34.17	0.50	0.17
Synoviocyte, donor2	11368-117I9	47.94	1.17	0.67
Synoviocyte, donor3	11440-118H9	57.64	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	56.10	2.14	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	51.53	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	55.11	1.62	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	30.04	0.43	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	32.47	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	28.63	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	45.15	0.49	0.49
Urethra, donor2	10319-105A4	26.98	3.60	0.00
Urothelial Cells, donor1	11520-119H8	53.13	0.27	0.27
Urothelial Cells, donor2	11600-120H7	51.27	0.40	0.40
Urothelial Cells, donor3	11681-122H7	41.49	0.23	0.69
Urothelial cells, donor0	11216-116B1	36.78	0.45	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	26.69	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	34.31	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	16.43	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	25.48	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	21.50	2.32	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	3.12	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	46.81	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.04	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	61.80	1.60	0.62
Wilms' tumor cell line:HFWT	10597-108E3	52.80	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	28.49	1.68	0.28
achilles tendon, donor2	10292-104G4	6.20	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	59.66	1.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	58.97	5.34	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	56.51	3.68	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	99.87	1.63	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	24.74	1.69	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	107.64	2.33	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.40	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	65.66	3.97	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	35.53	2.45	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	55.53	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	46.74	1.29	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	56.47	1.16	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.93	1.04	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.72	1.46	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	16.27	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	52.64	4.94	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	65.69	0.92	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	77.23	0.85	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	60.66	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	58.25	0.48	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	46.11	2.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	31.69	2.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	52.03	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	30.13	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	28.78	2.18	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	65.61	7.50	0.00
adenocarcinoma cell line:IM95m	10796-110I4	116.10	1.88	0.94
adipose tissue, adult, pool1	10010-101C1	22.03	0.47	0.16
adipose, donor1	10184-103D4	169.47	5.86	0.00
adipose, donor2	10185-103D5	54.34	3.24	0.81
adipose, donor3	10186-103D6	68.89	3.00	1.09
adipose, donor4	10187-103D7	88.41	6.07	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	86.17	3.79	2.21
adrenal gland, adult, pool1	10081-102A9	83.67	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	51.09	5.20	1.73
alveolar cell carcinoma cell line:SW 1573	10708-109H6	67.17	1.79	0.71
amniotic membrane cells, donor1	12235-129G3	74.66	1.39	3.01
amniotic membrane cells, donor2	12236-129G4	91.29	3.04	0.00
amniotic membrane cells, donor3	12237-129G5	68.35	0.00	1.18
amygdala - adult, donor10196	10167-103B5	55.73	3.56	8.30
amygdala, adult, donor10252	10151-102I7	59.21	3.04	2.23
amygdala, newborn, donor10223	10360-105E9	36.80	1.94	2.90
anaplastic carcinoma cell line:8305C	10428-106D5	15.92	0.76	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	129.95	1.76	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	53.11	9.35	0.67
aorta, adult, pool1	10052-101G7	39.42	1.18	0.39
appendix, adult	10189-103D9	33.38	2.33	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	86.67	6.88	0.69
artery, adult	10190-103E1	120.92	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	32.16	0.72	0.29
b cell line:RPMI1788	10427-106D4	15.76	1.93	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	81.01	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	43.17	1.19	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	61.09	1.51	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	33.55	2.24	1.12
bladder, adult, pool1	10011-101C2	23.25	1.74	0.22
blood, adult, pool1	10053-101G8	46.51	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	65.08	0.86	1.71
bone marrow, adult	10192-103E3	44.54	0.67	2.02
brain, adult, donor1	10084-102B3	95.33	3.08	2.05
brain, adult, pool1	10012-101C3	46.21	2.67	1.22
brain, fetal, pool1	10085-102B4	114.87	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	67.39	3.30	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	35.32	0.75	0.37
breast, adult, donor1	10080-102A8	36.62	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	49.42	1.14	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.69	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.85	3.22	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	73.59	2.91	1.45
carcinoid cell line:NCI-H1770	10703-109H1	76.17	9.40	0.47
carcinoid cell line:NCI-H727	10735-110B6	50.97	2.73	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	98.55	3.80	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	49.24	4.26	0.00
caudate nucleus - adult, donor10196	10177-103C6	80.59	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	79.81	3.51	5.86
caudate nucleus, adult, donor10258	10379-105H1	100.10	3.06	5.35
caudate nucleus, newborn, donor10223	10354-105E3	33.69	2.93	2.20
cerebellum - adult, donor10196	10173-103C2	58.27	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	58.72	5.34	0.43
cerebellum, adult, pool1	10083-102B2	89.00	6.21	0.69
cerebellum, newborn, donor10223	10357-105E6	41.51	4.98	0.00
cerebral meninges, adult	10188-103D8	67.83	3.53	3.53
cerebrospinal fluid, donor2	10294-104G6	59.20	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	59.96	9.63	0.29
cervical cancer cell line:ME-180	10553-107I4	37.62	0.66	0.33
cervix, adult, pool1	10013-101C4	23.83	1.57	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	41.94	2.09	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	40.49	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	37.66	2.36	0.12
choriocarcinoma cell line:SCH	10785-110H2	32.65	1.48	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	44.59	3.08	0.24
chorionic membrane cells, donor1	12238-129G6	53.56	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	62.44	1.39	0.50
chorionic membrane cells, donor3	12240-129G8	35.17	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	113.10	7.07	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	86.25	1.34	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	55.54	1.69	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	53.93	5.65	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	58.05	4.84	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	45.41	4.89	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	95.70	4.42	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	29.71	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	43.20	1.37	0.46
clear cell carcinoma cell line:TEN	10636-108I6	40.25	1.74	1.04
colon carcinoma cell line:CACO-2	10513-107D9	59.12	3.84	0.00
colon carcinoma cell line:COLO-320	10420-106C6	24.71	3.80	0.00
colon, adult, donor1	10082-102B1	130.90	1.19	0.00
colon, adult, pool1	10014-101C5	50.17	2.12	0.47
colon, fetal, donor1	10070-101I7	38.93	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	32.08	18.33	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	29.32	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	38.79	1.36	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	46.11	2.12	0.56
corpus callosum, adult, pool1	10042-101F6	59.59	5.86	2.21
cruciate ligament, donor2	10295-104G7	19.45	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	184.59	0.80	0.80
diencephalon, adult	10193-103E4	104.87	5.28	3.36
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	73.25	2.30	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	26.16	0.77	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	49.11	2.17	0.96
ductus deferens, adult	10196-103E7	48.34	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	79.21	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	47.08	2.21	0.00
dura mater, adult, donor1	10041-101F5	27.17	1.16	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	28.43	3.55	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	50.01	1.72	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	24.05	3.08	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	28.45	2.42	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	39.52	1.23	0.31
embryonic pancreas cell line:2C6	10603-108E9	64.36	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	43.58	4.02	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	40.42	3.44	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	64.33	0.32	1.29
epidermoid carcinoma cell line:A431	10426-106D3	23.57	0.67	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	47.73	1.21	0.33
epididymis, adult	10197-103E8	34.12	1.05	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	44.35	1.60	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	37.75	0.79	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	67.10	3.28	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	47.04	2.46	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	78.42	2.35	0.22
esophagus, adult, pool1	10015-101C6	38.22	0.96	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	33.19	1.63	0.38
eye - muscle inferior rectus, donor1	10272-104E2	43.46	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	65.23	0.00	0.00
eye - muscle medial, donor2	10299-104H2	59.53	0.00	0.00
eye - muscle superior, donor2	10297-104G9	49.30	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	33.52	0.00	0.00
eye, fetal, donor1	10054-101G9	68.64	0.76	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	39.49	1.03	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.51	1.19	0.00
frontal lobe, adult, pool1	10040-101F4	60.33	3.75	2.72
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.13	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	24.78	3.29	0.91
gall bladder, adult	10198-103E9	45.15	1.21	1.21
gamma delta positive T cells, donor1	11937-126A2	59.05	2.68	2.15
gamma delta positive T cells, donor2	11938-126A3	54.53	2.99	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	61.89	2.11	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	27.85	1.35	0.19
gastric cancer cell line:AZ521	10549-107H9	52.79	1.97	0.00
gastric cancer cell line:GSS	10560-108A2	27.46	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	36.32	3.66	0.69
giant cell carcinoma cell line:LU65	10487-107B1	27.31	1.84	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	13.30	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	50.63	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	24.70	1.16	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.48	1.40	0.56
glioblastoma cell line:T98G	10485-107A8	40.95	1.99	0.66
glioma cell line:GI-1	10413-106B8	28.12	2.93	1.46
globus pallidus - adult, donor10196	10175-103C4	101.32	5.83	2.19
globus pallidus, adult, donor10252	10161-103A8	80.55	4.15	1.95
globus pallidus, adult, donor10258	10367-105F7	117.75	2.74	6.85
globus pallidus, newborn, donor10223	10364-105F4	45.30	2.66	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	142.07	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	229.97	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	49.60	1.28	0.96
hIPS +CCl2, biol_rep1	14383-156B9	67.49	6.89	0.92
hIPS +CCl2, biol_rep2	14384-156C1	42.98	4.57	0.46
hIPS +CCl2, biol_rep3	14385-156C2	70.21	7.09	0.64
hIPS, biol_rep1	14380-156B6	28.75	4.31	1.44
hIPS, biol_rep2	14381-156B7	56.24	2.74	0.00
hIPS, biol_rep3	14382-156B8	81.66	3.31	2.21
hairy cell leukemia cell line:Mo	10712-109I1	39.94	0.29	1.15
heart - mitral valve, adult	10205-103F7	68.46	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	98.31	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	67.44	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	128.96	1.02	0.20
heart, adult, diseased, donor1	10051-101G6	208.23	0.43	0.00
heart, adult, pool1	10016-101C7	191.11	0.69	0.23
heart, fetal, pool1	10046-101G1	111.61	0.62	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	52.14	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	3.57	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	44.53	1.44	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	47.09	1.34	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	45.17	0.91	0.30
hepatoma cell line:Li-7	10484-107A7	49.16	0.89	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.78	3.42	0.30
hippocampus - adult, donor10196	10169-103B7	50.16	3.79	0.95
hippocampus, adult, donor10252	10153-102I9	51.43	2.45	2.25
hippocampus, adult, donor10258	10374-105G5	39.84	2.99	3.98
hippocampus, newborn, donor10223	10363-105F3	33.13	2.47	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	120.85	11.60	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	65.98	3.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	55.60	6.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	74.43	6.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	67.39	5.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	56.56	4.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	41.17	2.92	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	51.49	3.02	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	44.21	2.09	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	79.56	1.89	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	78.27	2.73	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	92.92	2.69	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	49.92	2.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	70.26	5.90	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	55.86	6.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	60.14	3.05	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	51.89	3.05	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	85.46	5.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.77	3.20	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	41.38	2.27	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.19	4.70	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	53.56	1.96	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	52.84	0.58	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	45.14	1.79	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	65.40	2.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	69.61	3.42	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	93.50	8.98	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	69.01	3.52	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	64.62	3.48	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	60.83	1.51	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.40	3.62	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	47.82	3.32	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	34.12	4.36	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	57.78	2.81	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	57.55	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	54.78	2.35	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	68.10	3.62	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	57.04	5.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	59.51	3.41	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	61.43	3.36	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	165.92	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	72.15	4.96	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	60.75	7.11	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	51.75	4.34	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	41.99	4.63	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	44.16	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	55.66	2.03	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	58.19	1.35	1.62
immature langerhans cells, donor1	11904-125F5	34.63	0.24	1.21
immature langerhans cells, donor2	11905-125F6	42.78	2.38	1.58
insula, adult, pool1	10039-101F3	63.69	2.65	4.83
keratoacanthoma cell line:HKA-1	10791-110H8	110.55	1.30	0.33
kidney, adult, pool1	10017-101C8	83.61	1.50	0.70
kidney, fetal, pool1	10045-101F9	52.56	0.64	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.81	2.56	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	41.06	2.76	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.03	2.02	0.37
left atrium, adult, donor1	10079-102A7	115.51	0.00	1.09
left ventricle, adult, donor1	10078-102A6	163.83	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	70.59	0.55	0.55
leiomyoma cell line:10964C	10569-108B2	78.32	1.08	3.59
leiomyoma cell line:15242A	10570-108B3	57.61	2.72	3.26
leiomyoma cell line:15425	10571-108B4	56.58	1.21	3.16
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	48.52	1.53	0.00
liposarcoma cell line:KMLS-1	10782-110G8	61.55	3.44	1.56
liposarcoma cell line:SW 872	10726-110A6	81.02	3.78	0.61
liver, adult, pool1	10018-101C9	50.40	0.16	0.00
liver, fetal, pool1	10086-102B5	50.80	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	53.66	2.19	2.48
locus coeruleus, adult, donor10252	10165-103B3	73.27	4.24	2.77
locus coeruleus, adult, donor10258	10375-105G6	73.64	4.23	2.54
locus coeruleus, newborn, donor10223	10362-105F2	27.76	2.52	1.68
lung adenocarcinoma cell line:A549	10499-107C4	44.84	2.08	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	47.57	1.38	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	40.73	4.48	0.53
lung, adult, pool1	10019-101D1	28.82	0.59	0.00
lung, fetal, donor1	10068-101I5	31.39	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	35.28	0.46	0.46
lymph node, adult, donor1	10077-102A5	29.82	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	67.51	2.63	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	153.79	5.28	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	15.29	0.00	0.00
mature adipocyte, donor1	12231-129F8	85.69	1.33	0.00
mature adipocyte, donor2	12232-129F9	87.58	1.87	0.42
mature adipocyte, donor3	12233-129G1	85.11	2.37	0.47
mature adipocyte, donor4	12234-129G2	75.81	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	34.07	2.38	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	95.88	4.51	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	58.85	3.68	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	108.97	4.13	3.18
medial frontal gyrus, newborn, donor10223	10352-105E1	58.43	4.69	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	60.58	1.52	3.71
medial temporal gyrus, adult, donor10252	10156-103A3	58.79	3.82	2.12
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	61.64	3.85	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	46.66	2.87	1.44
medulla oblongata - adult, donor10196	10174-103C3	86.31	2.60	1.95
medulla oblongata, adult, donor10252	10155-103A2	56.81	2.48	1.08
medulla oblongata, adult, pool1	10038-101F2	49.96	3.75	1.55
medulla oblongata, newborn, donor10223	10361-105F1	37.84	3.82	0.35
medulloblastoma cell line:D283 Med	10838-111E1	12.40	1.99	0.00
medulloblastoma cell line:ONS-76	10759-110E3	53.19	1.35	0.86
melanoma cell line:COLO 679	10514-107E1	102.92	1.87	1.58
melanoma cell line:G-361	10465-106H6	39.63	7.06	0.81
meningioma cell line:HKBMM	10691-109F7	36.54	1.45	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	79.30	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	102.91	2.85	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	93.90	1.07	1.69
mesenchymal precursor cell - adipose, donor2	11748-123G2	59.44	3.64	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	51.76	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	67.01	2.39	1.40
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.46	1.16	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.93	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	55.09	3.26	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	48.88	0.92	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	83.03	1.59	1.59
mesenchymal precursor cell - cardiac, donor4	11755-123G9	78.46	0.68	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	60.60	0.71	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.04	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	85.51	0.69	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	48.87	1.40	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	71.46	1.02	2.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.63	1.44	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	63.00	0.83	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	49.02	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	49.93	1.68	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	63.81	1.64	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	66.96	0.88	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.14	2.21	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.63	2.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	74.10	1.26	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	68.96	2.74	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	50.13	2.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	47.38	2.36	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	38.20	1.85	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	41.19	0.94	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	45.01	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	40.87	2.36	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	32.44	3.24	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	55.09	1.73	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	46.85	1.78	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	39.90	1.92	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	56.47	2.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	42.63	1.68	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	37.66	3.28	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	39.95	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	55.86	1.62	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	58.20	2.91	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	71.97	3.73	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	50.70	2.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.59	2.33	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	45.07	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	47.52	1.22	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	54.47	6.33	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	45.53	3.45	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	46.45	2.04	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	50.05	2.38	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.14	1.18	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	47.07	2.81	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	54.80	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	53.22	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	41.09	5.14	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	61.27	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	109.85	1.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	100.94	4.49	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	103.68	3.18	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	157.16	1.61	3.22
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	146.10	4.36	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	114.04	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	80.11	7.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	13.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	105.43	3.29	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	86.51	3.37	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	74.63	1.62	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	72.32	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.07	0.00	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	57.41	4.49	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	53.52	1.85	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	98.43	1.54	1.34
mesothelioma cell line:Mero-25	10850-111F4	18.38	1.36	0.23
mesothelioma cell line:Mero-41	10851-111F5	39.36	0.98	0.49
mesothelioma cell line:Mero-48a	10852-111F6	49.82	0.66	0.89
mesothelioma cell line:Mero-82	10853-111F7	30.75	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	26.89	0.85	0.68
mesothelioma cell line:Mero-84	10855-111F9	62.18	1.52	0.51
mesothelioma cell line:Mero-95	10856-111G1	32.09	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	16.23	0.66	0.33
mesothelioma cell line:NCI-H226	10846-111E9	44.52	0.54	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	33.48	1.54	0.34
mesothelioma cell line:NCI-H28	10845-111E8	61.07	4.07	0.76
mesothelioma cell line:No36	10857-111G2	36.53	1.63	0.65
mesothelioma cell line:ONE58	10858-111G3	19.51	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	23.03	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	17.58	0.24	0.37
migratory langerhans cells, donor3	11903-125F4	28.90	1.26	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	84.88	2.29	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	53.41	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.03	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	48.91	1.14	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	40.10	2.40	0.37
myeloma cell line:PCM6	10474-106I6	58.90	1.58	1.78
myxofibrosarcoma cell line:MFH-ino	10600-108E6	62.40	2.54	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	59.04	3.33	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	42.68	0.56	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	41.11	1.18	0.74
nasal epithelial cells, donor2	12227-129F4	32.57	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	62.12	7.36	0.00
neuroblastoma cell line:NB-1	10539-107G8	118.05	2.25	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	63.27	3.80	0.63
neuroblastoma cell line:NH-12	10555-107I6	51.06	4.29	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	27.04	3.08	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	56.07	1.27	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	94.99	2.21	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	57.85	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	61.22	0.80	1.33
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	106.25	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	23.00	3.72	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	407.46	16.01	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	55.46	1.28	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	59.38	3.15	2.36
nucleus accumbens, adult, pool1	10037-101F1	67.12	2.81	4.41
occipital cortex - adult, donor10196	10172-103C1	59.75	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	64.41	4.83	1.61
occipital cortex, newborn, donor10223	10355-105E4	33.48	2.55	0.73
occipital lobe, adult, donor1	10076-102A4	75.31	2.10	3.67
occipital lobe, fetal, donor1	10073-102A1	48.06	8.15	0.86
occipital pole, adult, pool1	10036-101E9	63.07	3.94	2.29
olfactory region, adult	10195-103E6	61.71	3.06	3.63
optic nerve, donor1	10277-104E7	60.03	8.00	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	39.18	2.05	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.43	2.20	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	29.80	0.68	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	31.07	1.16	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	42.04	0.88	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	48.59	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	39.44	1.91	0.21
ovary, adult, pool1	10020-101D2	20.70	1.22	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	78.09	2.20	1.83
pancreas, adult, donor1	10049-101G4	79.01	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	49.48	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	41.74	1.19	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.96	0.99	0.17
paracentral gyrus, adult, pool1	10035-101E8	73.86	2.47	3.02
parietal cortex, adult, donor10258	10373-105G4	61.66	0.73	4.40
parietal lobe - adult, donor10196	10171-103B9	63.01	3.76	1.88
parietal lobe, adult, donor10252	10157-103A4	57.29	4.28	0.86
parietal lobe, adult, pool1	10034-101E7	71.64	2.20	3.08
parietal lobe, fetal, donor1	10072-101I9	64.98	5.82	0.97
parietal lobe, newborn, donor10223	10356-105E5	35.14	5.61	2.24
parotid gland, adult	10199-103F1	48.72	1.85	0.00
penis, adult	10200-103F2	60.69	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	24.54	4.46	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	31.18	1.02	0.29
pineal gland - adult, donor10196	10179-103C8	61.92	5.16	1.29
pineal gland, adult, donor10252	10160-103A7	102.45	5.92	1.78
pineal gland, adult, donor10258	10377-105G8	77.76	4.39	0.63
pituitary gland - adult, donor10196	10180-103C9	49.58	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	74.01	1.04	1.04
pituitary gland, adult, donor10258	10378-105G9	66.40	3.40	0.85
placenta, adult, pool1	10021-101D3	25.80	0.00	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	26.35	1.46	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.49	0.93	0.31
pons, adult, pool1	10033-101E6	55.08	3.18	1.98
postcentral gyrus, adult, pool1	10032-101E5	78.55	3.84	3.40
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	4.18	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	181.77	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	222.98	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	56.66	5.97	0.73
prostate cancer cell line:PC-3	10439-106E7	134.31	2.00	0.00
prostate, adult, pool1	10022-101D4	36.10	1.45	0.45
putamen, adult, donor10196	10176-103C5	117.09	2.36	8.50
putamen, adult, donor10252	10152-102I8	137.25	7.84	5.88
putamen, adult, donor10258, tech_rep1	10372-105G3	50.27	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	77.80	1.69	5.32
putamen, newborn, donor10223	10365-105F5	32.24	2.25	0.75
rectal cancer cell line:TT1TKB	10469-106I1	27.64	1.16	0.29
rectum, fetal, donor1	10067-101I4	90.41	2.78	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	56.18	2.33	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	37.28	9.94	0.83
retina, adult, pool1	10030-101E3	64.11	2.09	0.40
retinoblastoma cell line:Y79	10475-106I7	56.64	10.91	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	56.43	1.48	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	68.61	5.91	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.10	1.52	0.76
salivary acinar cells, donor1	11771-123I7	22.34	2.10	0.49
salivary acinar cells, donor2	11772-123I8	16.52	0.69	0.41
salivary acinar cells, donor3	11773-123I9	15.89	1.32	0.66
salivary gland, adult, pool1	10093-102C3	86.36	1.72	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.48	1.35	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	23.51	2.23	0.47
seminal vesicle, adult	10201-103F3	34.92	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	30.61	0.73	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	52.84	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	59.21	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	57.76	2.01	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	38.57	1.33	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	66.58	0.77	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	129.10	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	76.52	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	44.22	0.00	1.01
skin, adult, donor1	10074-102A2	27.14	0.00	0.00
skin, fetal, donor1	10065-101I2	70.07	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	121.40	3.34	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	92.67	2.52	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	50.31	6.17	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	45.33	2.31	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	23.64	7.40	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	115.93	2.83	0.22
small intestine, adult, pool1	10024-101D6	64.38	0.72	0.36
small intestine, fetal, donor1	10064-101I1	72.97	0.98	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	90.27	7.18	4.10
smooth muscle, adult, pool1	10048-101G3	59.19	1.81	0.52
somatostatinoma cell line:QGP-1	10781-110G7	75.05	3.48	1.61
spinal cord - adult, donor10196	10181-103D1	64.92	2.75	0.92
spinal cord, adult, donor10252	10159-103A6	43.37	2.37	0.00
spinal cord, adult, donor10258	10369-105F9	67.10	5.53	2.08
spinal cord, fetal, donor1	10056-101H2	88.43	2.44	1.83
spinal cord, newborn, donor10223	10359-105E8	50.97	4.59	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	58.99	1.64	0.60
spleen, adult, pool1	10025-101D7	29.41	1.10	0.22
spleen, fetal, pool1	10044-101F8	27.81	1.35	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	26.29	1.14	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	16.33	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	65.70	0.70	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	13.29	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	47.95	2.59	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	40.24	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	39.35	1.69	0.00
stomach, fetal, donor1	10062-101H8	129.22	3.20	0.00
submaxillary gland, adult	10202-103F4	39.88	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	68.75	3.53	2.08
substantia nigra, adult, donor10258	10371-105G2	61.04	7.24	2.07
substantia nigra, newborn, donor10223	10358-105E7	31.09	4.24	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	84.60	3.44	0.46
temporal lobe, adult, pool1	10031-101E4	68.07	2.97	3.73
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	54.13	4.27	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	38.68	6.15	0.88
tenocyte, donor1	11763-123H8	63.89	1.05	1.40
tenocyte, donor2	11765-123I1	60.28	2.29	2.29
tenocyte, donor3	11768-123I4	78.95	1.85	3.34
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	95.86	5.78	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	66.44	3.85	0.15
teratocarcinoma cell line:PA-1	10807-111A6	92.52	1.24	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	38.08	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.66	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	46.35	1.09	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	30.94	2.93	0.33
testis, adult, pool1	10026-101D8	32.10	0.64	0.43
testis, adult, pool2	10096-102C6	41.05	0.90	0.90
thalamus - adult, donor10196	10168-103B6	79.49	6.62	1.10
thalamus, adult, donor10252	10154-103A1	55.48	5.47	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	72.36	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	75.43	1.98	1.15
thalamus, newborn, donor10223	10366-105F6	29.92	1.73	0.00
throat, adult	10209-103G2	53.93	1.50	0.00
throat, fetal, donor1	10061-101H7	101.77	2.44	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	49.09	2.58	0.79
thymus, adult, pool1	10027-101D9	29.63	0.80	0.20
thymus, fetal, pool1	10043-101F7	36.47	3.74	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	70.74	1.60	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	44.70	1.82	0.56
thyroid, adult, pool1	10028-101E1	105.07	1.77	0.65
thyroid, fetal, donor1	10060-101H6	182.19	3.16	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	0.00	0.00
tongue, adult	10203-103F5	77.22	1.40	0.47
tongue, fetal, donor1	10059-101H5	229.76	0.79	0.00
tonsil, adult, pool1	10047-101G2	39.67	1.60	0.60
trachea, adult, pool1	10029-101E2	35.66	0.98	0.74
trachea, fetal, donor1	10058-101H4	64.63	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	53.85	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	41.74	0.61	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	32.75	5.33	0.47
tridermal teratoma cell line:HGRT	10694-109G1	38.05	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	47.07	1.19	0.08
umbilical cord, fetal, donor1	10057-101H3	62.60	0.00	2.09
uterus, adult, pool1	10100-102D1	36.51	1.37	0.17
uterus, fetal, donor1	10055-101H1	74.23	4.10	0.51
vagina, adult	10204-103F6	23.26	1.29	0.00
vein, adult	10191-103E2	38.80	0.88	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	44.06	0.80	0.80

Property "Nearest transcripts" (as page type) with input value "ENST00000476470.5:153 ENST00000464566.5:-209 CR542121:-212 ENST00000471136.5:220 BC001168:-241 ENST00000476181.5:-247 BC063026:-247 ENST00000464564.6:-248 ENST00000247866.9:-249 NM_004546.3:-249 ENST00000465506.5:-267 ENST00000461457.1:-269 AF050639:-269 AF067166:-276 ENST00000476279.5:-286" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.